Related by context. All words. (Click for frequent words.) 70 immunomodulatory 69 selective inhibition 69 immune modulatory 68 immune modulator 67 anti fibrotic 67 Tß4 66 liposomal formulation 66 Symadex 66 preclinically 66 Nanobody ® 66 novel peptide 66 targeted antifolate 66 Hedgehog signaling pathway 65 siRNA therapeutics 65 fibrotic disease 65 engineered RAP peptides 65 depsipeptide 65 potent antiproliferative 65 Fc fusion protein 65 targeting CD# 65 novel immunotherapeutic 65 Guanilib 65 HSP# inhibitor 65 cytoprotective 65 novel peptides 65 fosbretabulin 65 antitumoral 65 Factor VIIa 65 potent anticancer 65 investigational humanized monoclonal antibody 64 TLR9 agonist 64 antisense inhibitors 64 intranasal delivery 64 mda 7 64 histone deacetylase inhibitor 64 proteasome inhibitors 64 histone deacetylase HDAC 64 neuroprotective 64 immunoregulatory 64 histone deacetylase inhibitors 64 vascular disrupting agents 64 epigenetic therapies 64 Homspera TM 64 targeted radiotherapeutic 64 EGFR pathway 64 dasatinib Sprycel 64 histamine dihydrochloride 64 GW# [003] 64 mTOR mammalian target 64 PKC# 64 telomerase activator 64 EGS# 64 proteasome inhibitor 64 Angiocept 64 preclinical efficacy 64 oral prodrug 64 deacetylase inhibitors 64 targeting PCSK9 64 antifibrotic 64 VEGF receptor 64 YONDELIS 63 Nanobody 63 humanized monoclonal 63 small molecule activators 63 Rasagiline 63 IAP inhibitor 63 IGF IR 63 kidney urologic 63 acadesine 63 hedgehog pathway 63 BiTE 63 insulin sensitizing 63 anti CD3 63 TLR8 63 vivo validation 63 angiogenesis inhibitor 63 NTDDS 63 antiangiogenic 63 receptor PPAR 63 NF kB pathway 63 TÎ ² 4 63 Cethrin R 63 mGlu2 3 63 Enzastaurin 63 pharmacological chaperone 63 acetylcholinesterase AChE 63 selective adenosine 63 CBLC# 63 immunomodulation 63 anticancer therapeutics 63 protein tyrosine phosphatase 1B 63 Zybrestat 63 potently inhibit 63 cannabinor 63 #ME# 63 PI3K inhibitors 63 Aviptadil 63 pan HDAC inhibitor 63 midstage clinical 63 novel anticancer 63 selective modulator 63 JAK inhibitors 63 nicotinic acetylcholine receptor 63 peroxisome proliferator activated 63 Squalamine 63 R roscovitine 63 bortezomib Velcade 63 small molecule inhibitors 63 therapeutic monoclonal antibody 63 thyroid hormone receptor 63 MAGE A3 ASCI 63 PDE4 inhibitor 63 IGF 1R 62 CEQ# 62 seliciclib 62 ALN TTR# 62 immunomodulating 62 ENMD # 62 antimitotic 62 SinuNase ™ 62 neuroprotection 62 immunomodulator 62 HCV protease 62 incretin 62 investigational therapies 62 TLR Therapeutics 62 PCK# 62 Anticalin R 62 cMET 62 BiTE R 62 Tβ4 62 Homspera 62 anti angiogenic drugs 62 antitumor 62 Panzem 62 Carfilzomib 62 Locked Nucleic Acid LNA 62 masitinib 62 anti CD3 antibody 62 allosteric modulation 62 siRNA delivery 62 potent cytotoxic 62 Combivir Kivexa 62 receptor tyrosine kinase inhibitor 62 inhibit angiogenesis 62 immune stimulatory 62 JAK3 62 selectively inhibit 62 microtubule inhibitor 62 small molecule modulators 62 Selective Electrochemical Tumor Ablation 62 Prodarsan ® 62 effector function 62 HCV protease inhibitors 62 CCR9 antagonist 62 antibody MAb 62 neuro protective 62 Pyridorin 62 Blinatumomab 62 exon skipping 62 pharmacologic approaches 62 mimetics 62 PORxin TM 62 Gleevec resistant 62 GMX# 62 monoclonal antibody mAb 62 Bendavia 62 Apoptone 62 glucocorticoid receptor 62 protein kinase inhibitors 62 antiapoptotic 62 isoform selective 62 insulin sensitizer 62 anticancer agent 62 CCR9 62 C1 inhibitor rhC1INH 62 adenosine receptor 62 DiLA2 62 Janus kinase 62 Romiplostim 62 HepDirect R 62 angiogenesis inhibition 62 immunotoxin 62 AT1R 62 NS5A 62 HDL Therapy 62 Homspera ® 62 chimeric monoclonal antibody 62 mGluR2 62 ATL# [001] 62 Enkephalin 62 antisense inhibitor 62 cytostatic 62 Vascular Endothelial Growth 62 APOPTONE 62 BRAF inhibitors 62 Panzem R 62 molecular biomarkers 62 HDL Mimetic Peptide 62 Onconase 62 oral Janus kinase 62 pro angiogenic 62 anti angiogenic 62 antiangiogenesis 62 humanized anti 62 MEK inhibitors 62 antisense oligonucleotide 62 vascular disrupting agent 62 Ecallantide 62 Corgentin 62 bevacizumab Avastin ® 62 potentiator 62 SomatoKine 62 multi kinase inhibitor 62 AAG geldanamycin analog 62 molecularly targeted 62 sd rxRNA 62 Ceflatonin R 62 Stapled Peptide 62 Immunotherapeutic 62 aurora kinase 62 peripherally acting 62 novel immunomodulatory 62 NEUGENE R 62 small molecule tyrosine 61 immune modulating 61 CXB# 61 microtubule targeting 61 PSMA ADC 61 Talabostat 61 trastuzumab Herceptin 61 PSN# [002] 61 Preclinical studies suggest 61 renoprotective 61 vinca alkaloid 61 INS# [001] 61 chemokine receptor 61 mGluR2 NAM 61 immunotherapeutics 61 renin angiotensin aldosterone 61 MEK inhibitor 61 therapeutic monoclonal antibodies 61 siRNA mediated 61 synthetic retinoid 61 sodium glucose cotransporter 61 IFN β 61 intranasal formulation 61 ZFP TF 61 endothelin receptor 61 neurotrophic 61 renal fibrosis 61 ALN PCS 61 Azedra 61 SGLT2 inhibitors 61 immunoregulation 61 oral antiviral 61 vidofludimus 61 PI3K/mTOR 61 peptibody 61 humanized monoclonal antibodies 61 ON #.Na 61 PRT# 61 p# inhibitor 61 Degarelix 61 PI3 kinase inhibitors 61 preclinical studies 61 CA4P 61 VitiGam 61 osteogenic 61 pharmacodynamic properties 61 mertansine 61 busulfan 61 potent inhibitors 61 trodusquemine 61 erlotinib Tarceva ® 61 EndoTAG TM 61 ANG# 61 histone deacetylase 61 IAP inhibitors 61 thalidomide Thalomid 61 Maxy G# 61 receptor inhibitor 61 JAK2 inhibitor 61 tkRNAi 61 tyrosine kinase inhibitor 61 selective antagonist 61 TELINTRA 61 FGFR 61 OXi# 61 neurogenic 61 JAK1 61 DOS# 61 antisense 61 Granulocyte Colony Stimulating Factor 61 mu opioid receptor antagonist 61 Protexia ® 61 lipid nanoparticle 61 geldanamycin 61 Prodarsan R 61 anti atherogenic 61 liposomal 61 anti proliferative 61 Spiegelmers ® 61 induces apoptosis 61 eniluracil 61 P#X# 61 CD# monoclonal antibody 61 Dalbavancin 61 PEG SN# 61 CTAP# Capsules 61 bioactive lipids 61 Tumor Necrosis Factor 61 histone deacetylase HDAC inhibitor 61 COX2 61 DFMO 61 prostanoid 61 intracellular signaling pathways 61 ZFP Therapeutic 61 BiTE ® 61 resolvins 61 JAK inhibitor 61 glucagon receptor 61 Traficet EN 61 erlotinib Tarceva 61 leukotriene pathway 61 Cannabinor 61 AQ4N 61 adenosine A2A 61 Xanafide 61 ganetespib 61 anticancer therapy 61 hypoxia inducible factor 61 Kuvan sapropterin dihydrochloride 61 small molecule defensin 61 NV1FGF 61 remyelination 61 Upregulation 61 neuronal differentiation 61 PPARgamma 61 highly selective inhibitor 61 antiproliferative effects 61 Beta catenin pathway 61 aberrantly activated 61 histone deacetylase HDAC inhibitors 61 TLK# 61 MET VEGFR2 61 cyclooxygenase 61 Liposomal 61 A3 adenosine receptor 61 neuroprotective properties 61 oncolytic viruses 61 therapeutic peptide 60 ZFP TFs 60 CTLA 4 60 EGF receptor 60 PI3K Akt 60 CCR2 60 kinase pathway 60 RNAi therapeutic targeting 60 virotherapy 60 oncolytic 60 KRN# 60 PrevOnco 60 anticancer therapies 60 EGFR signaling 60 uricase 60 selective agonist 60 Anticalins ® 60 xenograft models 60 oligonucleotide therapeutics 60 trastuzumab Herceptin ® 60 myelofibrosis polycythemia vera 60 immunomodulatory effects 60 CYT# potent vascular disrupting 60 histone acetyltransferase 60 Vidaza azacitidine 60 mediated inhibition 60 immunostimulatory 60 nicotinic alpha 7 60 theranostic 60 pharmacologic 60 Omacetaxine 60 SPC# [001] 60 liposomal delivery 60 TNFalpha 60 prodrugs 60 anti infective treatments 60 cancer immunotherapies 60 alkylating agent 60 GRNCM1 60 EP #R 60 CTGF 60 PPARγ 60 HTS assay 60 thrombopoietin 60 Preclinical studies 60 ligand TRAIL 60 experimental autoimmune encephalomyelitis 60 HuMax TAC 60 Selzentry Celsentri 60 novel histone deacetylase 60 biased ligand 60 YONDELIS R 60 imatinib Gleevec ® 60 antithrombotic 60 LNP formulations 60 HGS# 60 mTOR inhibitors 60 CGEN # 60 diarrhea predominant irritable 60 PXD# 60 #beta HSD1 60 HuLuc# 60 Vidofludimus 60 Temsirolimus 60 EGFR HER 60 NP2 Enkephalin 60 partial agonist 60 proprietary transdermal 60 pertuzumab 60 delipidation 60 Chemokine Therapeutics 60 sorafenib Nexavar 60 INGN 60 Ceflatonin 60 TLR antagonists 60 Cytotoxic T 60 peptide hormone 60 vorinostat 60 stable nucleic acid 60 HSP# inhibitors 60 cellular immunotherapy 60 pharmacodynamic PD 60 phosphatidylserine PS targeting 60 gefitinib Iressa 60 Elvitegravir 60 investigational monoclonal antibody 60 Angiolix 60 Seliciclib 60 sorafenib tablets 60 apoptotic pathway 60 UsiRNAs 60 Hedgehog pathway 60 5 HT4 receptor 60 Thymosin beta 4 60 Sphingomab 60 triphendiol 60 PNP inhibitor 60 Staccato nicotine technology 60 predictive toxicology 60 immune modulators 60 RNA interference RNAi therapeutics 60 SCH # 60 IGFBP2 60 Epidermal Growth Factor Receptor 60 humanized monoclonal antibody 60 preclinical 60 diagnostic molecular imaging 60 PI3K inhibitor 60 antibody fragment therapeutics 60 bispecific 60 GGTase 60 prostaglandin D2 60 sphingosine kinase 60 CDK inhibitor 60 LHRH antagonists 60 induce apoptosis 60 monoclonal anti 60 PhG alpha 1 60 Kahalalide F 60 selectively inhibited 60 Cetrorelix 60 Exherin TM 60 allogeneic cell 60 antisense drug 60 ERK1 2 60 Aganocide ® 60 ixabepilone 60 MGd 60 dexanabinol 60 Ataluren 60 IgG1 antibody 60 receptor agonists 60 activate SIRT1 60 ganaxolone 60 anti amnesic 60 TNFa 60 potent topoisomerase II 60 orally bioavailable 60 TRV# [001] 60 HDAC inhibition 60 nucleoside analog 60 CB1 antagonists 60 Anti angiogenic 60 antibody mediated 60 PEGylated interferon 60 M1 muscarinic 60 TRX1 60 molecular chaperone 60 Protectan CBLB# 60 MabThera rituximab 60 Factor Receptor 60 small molecule agonists 60 PLX cells 60 Sapacitabine 60 alagebrium 60 monocytes macrophages 60 Factor VEGF 60 systemic RNAi 60 chemopreventive agent 60 mecamylamine 60 Endothelin 60 Pathway Inhibitor 60 prostaglandin synthesis 60 antimetastatic 60 Cloretazine R 60 panitumumab Vectibix 60 XmAb ® 60 tumor hypoxia 60 otelixizumab 60 evaluating tivozanib 60 IMiD 60 chemokine 60 factor TNF 60 riociguat 60 alpha7 60 Fleximer 60 gastrin 60 NF kappa B 60 potent inhibitor 60 immunotherapeutic vaccine 60 TGR5 60 Valdoxan 60 Hsp# inhibitors 60 neuroprotectant 60 CORT # 60 cAMP signaling 60 Zalypsis 60 inverse agonist 60 potently inhibited 60 nonviral 60 Aurora Kinase 60 AEG# 60 Aplidin R 60 Fibroblast Growth Factor Receptor 60 huC# DM4 60 GED aPC 60 CXCR7 60 RhuDex ® 60 PDE7 inhibitors 60 cediranib 60 TNFα 60 TB4 60 DXL# 60 Litx 60 TRO# 60 antibody MT# 60 opioid antagonists 60 NPC 1C 60 kinase inhibitor 60 orally inhaled migraine 60 peptidic compound 60 interleukin IL -# 60 HDACi 59 reslizumab 59 THR beta agonist 59 siRNA therapeutic 59 antiproliferative 59 neuroinflammatory 59 Hedgehog signaling 59 tranilast 59 PDGF B 59 sd rxRNA compounds 59 systemic RNAi therapeutic 59 kallikrein 59 p# MAPK 59 CB2 receptor 59 mTOR inhibitor 59 ErbB3 59 PDX pralatrexate 59 radionuclide therapy 59 neuroregenerative 59 CD# antibody [001] 59 mediated apoptosis 59 renin inhibitors 59 AMD# [003] 59 OTCBB HPLF FWB HL1 59 cell adhesion molecule 59 PDE4 59 CTLA4 Ig 59 Presents Preclinical Data 59 delta isoform 59 3 kinase PI3K 59 EZN 59 HepDirect prodrug 59 Galectin 59 myeloproliferative diseases 59 FVIIa 59 antitumour 59 apoptosis inducing 59 nucleotide analog 59 TLR9 59 MAXY G# 59 PI3K delta 59 Methylnaltrexone 59 signaling cascades 59 intracellular protein 59 enzyme inhibitors 59 Schisandrin B 59 SYN# 59 receptor subtypes 59 GHRH 59 ALN TTR 59 therapeutic 59 cilengitide 59 adult mesenchymal stem 59 protein tyrosine phosphatases 59 CB2 selective receptor agonist 59 telomerase activation 59 gene silencing 59 cartilage regeneration 59 Chemokine 59 ONCONASE R 59 calcitonin gene related 59 opioid receptor antagonist 59 vitro studies 59 RECOTHROM R 59 antisense oligonucleotides 59 taxane derivative 59 novel VDA molecule 59 receptor antagonists 59 IMiDs R 59 GSK# [002] 59 pregabalin Lyrica 59 Protein Kinase C 59 Aplidin 59 CCX# 59 antiangiogenic agent 59 immunomodulators 59 fatty acid amide hydrolase 59 SERCA2a 59 matrix metalloproteases 59 acetonide FA 59 Denufosol 59 hyaluronidase enzyme 59 TLR7 59 GSK3B 59 NKG2D 59 Anticalin ® 59 bioartificial liver 59 melanocortin receptors 59 Vilazodone 59 Hsp# inhibition 59 sodium thiosulfate STS 59 Nasdaq SGMO announced 59 PI3 kinase 59 PARP inhibitors 59 ibudilast 59 STEDESA 59 Aganocide 59 factor G CSF 59 AEGR 59 bioscavenger 59 Anavex #-# 59 CD3 monoclonal antibody 59 targeted covalent 59 IMC A# 59 gamma secretase inhibitors 59 neurite outgrowth 59 HIF 1a 59 Solorel TM 59 Modrenal 59 PTP 1B 59 cancer immunotherapy 59 IL 1ß 59 selective inhibitors 59 immunosuppressive 59 Anticalins R 59 naturally occurring molecule 59 G Protein Coupled 59 plasma kallikrein 59 humanized antibodies 59 immuno modulatory 59 Factor Xa inhibitor 59 monoclonal antibody 59 BRAF inhibitor 59 casein kinase 59 antitumor efficacy 59 TRIOLEX 59 erythropoietic 59 sphingosine 1 59 HQK 59 Systemic Delivery 59 Pertuzumab 59 Fc receptor 59 vaccines oncolytic virus 59 Lisofylline 59 IMA# 59 5 HT6 receptor 59 antiinflammatory 59 Curaxin CBLC# 59 GeneICE 59 CCR1 59 Bendamustine 59 potent anti angiogenic 59 IL 1β 59 AZX# 59 orally dosed 59 Monoclonal antibody 59 E#F# 59 beta 1a 59 Locked Nucleic Acid 59 Onalta 59 kinase inhibition 59 Noxafil 59 Neo Kidney Augment 59 RNA silencing 59 act synergistically 59 peptide CGRP 59 inhibit metastasis 59 oral JAK1 59 Nasdaq IDRA 59 multicenter Phase II 59 VEGF inhibitors 59 orally administered inhibitor 59 small molecule thrombopoietin 59 EndoTAG TM -1 59 TLE3 59 Bruton tyrosine kinase 59 systemic fungal infections 59 HyACT 59 iroxanadine 59 OMP #M# 59 mitogen activated ERK kinase 59 adalimumab Humira 59 cetuximab Erbitux R 59 E1 INT TM 59 CYC# 59 antiarrhythmic 59 NFkappaB 59 pathophysiological effects 59 epothilone 59 systemically administered 59 P#X# antagonist 59 receptor agonist 59 Multimeric 59 alpha#beta# 59 virus AAV 59 Tyrima 59 humanised monoclonal antibody 59 immunotherapeutic 59 tumorigenicity 59 ViaCyte 59 CCR5 antagonist 59 visilizumab 59 antibiofilm 59 immunotoxins 59 pegylated 59 OTCBB CVBT 59 monoclonal 59 ALK inhibitor 59 FOLOTYN ® 59 immunological diseases 59 Cathepsin B 59 humanized antibody 59 Regado Biosciences 59 demonstrated antitumor activity 59 atacicept 59 somatostatin analogue 59 XL# inhibits 59 NP2 59 HepaLife Technologies Inc. 59 coronary vasodilation 59 VAPRISOL 59 anti secretory 59 Alfacell proprietary ribonuclease 59 muscarinic 59 dasatinib Sprycel ® 59 rNAPc2 59 CG# [003] 59 oral mTOR inhibitor 59 seliciclib CYC# 59 Smoothened 59 QuadraSphere 59 neuronal nicotinic receptors NNRs 59 Pimavanserin 59 lexidronam injection 59 Sym# 59 V#F mutation 59 Bryostatin 59 Cytochrome P# 59 nalbuphine ER 59 HER2 overexpression 59 Interferon alpha 59 oncolytic virus 59 Molecular Cancer 59 pertussis toxin 59 rxRNA 59 recombinant antibodies 59 estrogen receptor beta 59 developing TB4 59 Cyclosert 59 alpha antagonist 59 HMG CoA reductase inhibitors 59 mitogenic 59 Phase 1a clinical 59 molecular imaging radiopharmaceutical 59 tiapamil 59 AMPAKINE 59 IL #E 59 retinoic acid receptor 59 LPA1 receptor 59 ProMune 59 phase IIa clinical 59 Clusterin 59 radiotherapeutic 59 NF kappaB activation 59 OncoGel 59 ISF# 59 vesicular monoamine transporter 59 adrenoceptor 59 PSN# [001] 59 BioNumerik 59 GLP toxicology studies 59 IgG1 monoclonal antibody 59 HepDirect 59 anticancer agents 59 thymosin beta 4 59 Cethrin 59 Aliskiren 59 indibulin 59 RNA antagonist 59 cathepsin K inhibitor 59 docetaxel Taxotere ® 59 recurrent glioblastoma multiforme 59 radiosensitivity 59 DepoVax 59 opiate analgesic 59 gastro intestinal inflammation 59 Bezielle 59 Myolimus 59 preclinical models 59 NEUGENE antisense 59 nicotinic 59 Pervasis 59 teriflunomide 59 LPM TM 59 gabapentin Neurontin 59 BAY #-# 59 IL# PE#QQR 59 Vitaxin 58 accumulate preferentially 58 pro apoptotic 58 Quinamed 58 cyclin dependent kinase inhibitor 58 Trofex 58 ESBA# 58 hormone LHRH antagonist 58 HGS ETR2 58 Kinoid 58 tumorigenesis 58 Spiegelmer ® 58 Nasdaq IDRA today 58 Neuroprotective 58 vivo 58 radiation sensitizer 58 tasimelteon 58 partial agonists 58 rHuPH# recombinant human 58 varespladib 58 annexin 58 myeloproliferative disorders 58 Omacetaxine mepesuccinate 58 Antisense 58 Solulin 58 Sphingomab TM 58 polycythemia vera PV 58 CGRP 58 IRX 2 58 Fx #A 58 Bicifadine 58 BioSET 58 treating neuropathic pain 58 sunitinib Sutent ® 58 S1P 58 agonists antagonists 58 Preclinical Study 58 Angiotensin II 58 enzastaurin 58 PDGF receptor 58 cyclooxygenase 2 58 anti VEGF 58 beta Estradiol 58 Virulizin ® 58 Davanat 58 Silodosin 58 IFN alpha 58 DAS# Fludase ® 58 HCV protease inhibitor 58 neurotrophic factors 58 radiolabeled 58 Actimmune ® 58 PEGylated anti 58 PHX# 58 STAT3 signaling 58 TLR agonists 58 nicotinic receptor 58 Factor Xa 58 PD LID 58 signal transduction inhibitor 58 receptor mediated 58 SAR# [004] 58 antibody blinatumomab MT#/MEDI-# 58 Tarvacin 58 HDL Selective Delipidation 58 neuronal nitric oxide synthase 58 HuMax EGFr 58 Golimumab 58 nitric oxide donating prostaglandin 58 Tesmilifene 58 Dapagliflozin 58 5 HT6 58 c myc 58 liposomal doxorubicin 58 PROT biotechnology 58 poly ADP ribose polymerase 58 ERK signaling 58 TLR8 agonist 58 MAPK pathway 58 Inosine 58 fusion proteins 58 Telintra 58 insulin sensitizers 58 CaPre TM 58 chemotherapeutic agent 58 demethylating agents 58 vivo efficacy 58 Phase Ib II 58 generation purine nucleoside 58 thymidylate synthase TS 58 selective androgen receptor modulators 58 Tyrosine Kinase Inhibitor 58 Vaxfectin TM 58 ARIKACE ™ 58 5 HT2A serotonin 58 biotherapeutic 58 phase IIb clinical 58 NexACT 58 Posiphen 58 GLP 1R 58 Histone deacetylase 58 Milnacipran 58 Ampakine 58 hERG 58 HER2 ErbB2 58 ImmunoVEX HSV2 58 antiproliferative activity 58 reversible inhibitor 58 antidiabetic 58 Lu AA# 58 DAVANAT 58 HuMax CD# 58 biologic therapeutics 58 antagomirs 58 GM CSF 58 tafamidis 58 Zenvia ™ 58 EGFr 58 MIS# 58 investigational immunotherapy 58 Personalized Immunotherapy 58 Bucindolol 58 adipogenic 58 TAFA# 58 Safinamide 58 Valproic acid 58 Panzem NCD 58 Lpathomab 58 autologous cell 58 pDCs 58 Cx# [002] 58 deacetylase 58 ERK pathway 58 obatoclax 58 GRNVAC1 58 intracellular signaling 58 HCV replication 58 eIF 4E 58 non nucleoside 58 selectively inhibits 58 NMDA antagonist 58 short interfering RNA 58 5 HT2A receptor 58 Catena ® 58 TACI Ig 58 androgen receptor AR 58 pharmacological 58 penetrating peptides 58 Romidepsin